The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung.
Although studies indicate that alveolar macrophages participate in host defense against Pneumocystis carinii, their role in organism degradation and clearance from the lung has not yet been established. We, therefore, quantified the uptake and degradation of 35S-labeled P. carinii by cultured macrophages, demonstrating significant degradation of P. carinii over 6 h. We further evaluated the role of macrophages in elimination of P. carinii from the living host. Rats received either intratracheal PBS, liposomal PBS (L-PBS), or liposomal dichloromethylene diphosphonate (L-Cl2MDP), a preparation which leads to selective depletion of macrophages. Over 72 h, L-Cl2MDP-treated animals had loss of > 85% of their alveolar macrophages. In contrast, L-PBS-treated rats had cellular differentials identical to rats receiving PBS. Macrophage-depleted rats and controls were next inoculated with P. carinii and organism clearance was determined after 24 h. P. carinii elimination was evaluated with both cyst counts and an ELISA directed against glycoprotein A (gpA), the major antigen of P. carinii. Both assays indicated that macrophage-depleted rats had substantial inpairment of P. carinii clearance compared to L-PBS- or PBS-treated rats. These data provide the first direct evidence that macrophages mediate elimination of P. carinii from the living host.
Limper
A H
AH
Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Hoyte
J S
JS
Standing
J E
JE
D000818:Animals; D000911:Antibodies, Monoclonal; D002478:Cells, Cultured; D004002:Clodronic Acid / Q000008:administration & dosage*; D015169:Colony Count, Microbial; D004337:Drug Carriers; D004797:Enzyme-Linked Immunosorbent Assay; D005656:Fungal Proteins / Q000032:analysis; D008081:Liposomes; D016676:Macrophages, Alveolar / Q000502:physiology*; D008562:Membrane Glycoproteins / Q000032:analysis; D009079:Mucociliary Clearance / Q000276:immunology; D010587:Phagocytosis; D011010:Pneumocystis / Q000276:immunology*; D011020:Pneumonia, Pneumocystis / Q000276:immunology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013047:Specific Pathogen-Free Organisms
D000911:Antibodies, Monoclonal; D004337:Drug Carriers; D005656:Fungal Proteins; D008081:Liposomes; D008562:Membrane Glycoproteins; D004002:Clodronic Acid; C077556:GPA protein, Pneumocystis carinii sp.